CI
ABBV icon

Cavalier Investments’s AbbVie ABBV Stock Holding History

Cavalier Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,448
Closed -$213K – 129
2016
Q2 		$213K Sell
3,448
-995
-22% -$60.6K 0.12% 111
2016
Q1 		$254K Sell
4,443
-954
-18% -$53.2K 0.15% 87
2015
Q4 		$320K Buy
+5,397
New +$311K 0.19% 84

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cavalier Investments's ABBV Position: Q3 2016 in Review

Cavalier Investments sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 3,448 shares — an estimated $213K sold.

Cavalier Investments first reported a position in ABBV in Q4 2015 and held it in 3 quarters. The position peaked at $320K in Q4 2015. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Cavalier Investments reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
  • Cavalier Investments sold 3,448 AbbVie shares in Q3 2016, an estimated $213K.
  • Cavalier Investments first reported a position in AbbVie in Q4 2015 and held it in 3 quarters.
  • Cavalier Investments's AbbVie position peaked at $320K in Q4 2015.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Cavalier Investments's 13F filing for Q3 2016, filed 14 Nov 2016.